Kang et al., 2018 - Google Patents
Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopyKang et al., 2018
- Document ID
- 79708237033970194
- Author
- Kang Y
- Shao Z
- Wang Q
- Hu X
- Yu D
- Publication year
- Publication venue
- Journal of Pharmaceutical and Biomedical Analysis
External Links
Snippet
Entecavir was used for the treatment of chronic hepatitis B through inhibiting hepatitis B virus. The anhydrous form of entecavir (ENT-A) often appeared as impurity polymorph in the manufacturing process of entecavir monohydrate (ENT-H) such as granulation, drying and …
- 229960000980 entecavir 0 title abstract description 126
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infra-red light
- G01N21/3563—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infra-red light for analysing solids; Preparation of samples therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/71—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light thermally excited
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/21—Polarisation-affecting properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRA-RED, VISIBLE OR ULTRA-VIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J5/00—Radiation pyrometry
- G01J5/0003—Radiation pyrometry for sensing the radiant heat transfer of samples, e.g. emittance meter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRA-RED, VISIBLE OR ULTRA-VIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J5/00—Radiation pyrometry
- G01J2005/0048—Calibrating; Correcting
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRA-RED, VISIBLE OR ULTRA-VIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colour
- G01J3/28—Investigating the spectrum
- G01J3/45—Interferometric spectrometry
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kang et al. | Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy | |
| Heinz et al. | Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy | |
| Stephenson et al. | Characterization of the solid state: quantitative issues | |
| Croker et al. | A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetam | |
| Heinz et al. | Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy | |
| Chavan et al. | Near infra red spectroscopy: a tool for solid state characterization | |
| Aaltonen et al. | Perspectives in the use of spectroscopy to characterise pharmaceutical solids | |
| Li et al. | Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy | |
| Simone et al. | Application of quantitative Raman spectroscopy for the monitoring of polymorphic transformation in crystallization processes using a good calibration practice procedure | |
| Caliandro et al. | Multivariate analysis of quaternary carbamazepine–saccharin mixtures by X-ray diffraction and infrared spectroscopy | |
| Offerdahl et al. | Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopy | |
| Mah et al. | Use of low-frequency Raman spectroscopy and chemometrics for the quantification of crystallinity in amorphous griseofulvin tablets | |
| Kogermann et al. | Establishing quantitative in-line analysis of multiple solid-state transformations during dehydration | |
| Munjal et al. | Applications of synchrotron powder X-ray diffractometry in drug substance and drug product characterization | |
| CN104059052A (en) | Hydrates Of 3-(4-amino-1-oxo-1,3 Dihydro-isoindol-2-yl)-piperidine-2,6-dione | |
| Qiu et al. | Quantification of febuxostat polymorphs using powder X-ray diffraction technique | |
| US9625390B2 (en) | Determining percent solids in suspension using Raman spectroscopy | |
| Reddy et al. | Monitoring of multiple solvent induced form changes during high shear wet granulation and drying processes using online Raman spectroscopy | |
| da Costa et al. | Measurement of the amorphous fraction of olanzapine incorporated in a co-amorphous formulation | |
| Erxleben | Application of vibrational spectroscopy to study solid-state transformations of pharmaceuticals | |
| Correa-Soto et al. | Second harmonic generation microscopy as a tool for the early detection of crystallization in spray dried dispersions | |
| Wood et al. | Near infra red spectroscopy as a multivariate process analytical tool for predicting pharmaceutical co-crystal concentration | |
| DK2710355T3 (en) | METHOD OF DETERMINING POLYMORPHS USING SYNCROTRON RADIATION | |
| Skrdla et al. | Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC | |
| Xie et al. | Characterization of mannitol polymorphic forms in lyophilized protein formulations using a multivariate curve resolution (MCR)-based Raman spectroscopic method |